$Eagle制药(EGRX)$ 8-K - Current report Filed: 2017-04-28 AccNo: 0001104659-17-027952 Size: 332 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接